Athersys (ATHX) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrends ATHX vs. OGEN, SHPH, REVB, DWTX, LIPO, QNRX, VRPX, ENVB, PBM, and INMShould you be buying Athersys stock or one of its competitors? The main competitors of Athersys include Oragenics (OGEN), Shuttle Pharmaceuticals (SHPH), Revelation Biosciences (REVB), Dogwood Therapeutics (DWTX), Lipella Pharmaceuticals (LIPO), Quoin Pharmaceuticals (QNRX), Virpax Pharmaceuticals (VRPX), Enveric Biosciences (ENVB), Psyence Biomedical (PBM), and InMed Pharmaceuticals (INM). These companies are all part of the "pharmaceutical preparations" industry. Athersys vs. Oragenics Shuttle Pharmaceuticals Revelation Biosciences Dogwood Therapeutics Lipella Pharmaceuticals Quoin Pharmaceuticals Virpax Pharmaceuticals Enveric Biosciences Psyence Biomedical InMed Pharmaceuticals Oragenics (NYSE:OGEN) and Athersys (NASDAQ:ATHX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations, dividends, community ranking and media sentiment. Which has preferable valuation & earnings, OGEN or ATHX? Oragenics has higher earnings, but lower revenue than Athersys. Oragenics is trading at a lower price-to-earnings ratio than Athersys, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOragenics$40K82.45-$20.66M-$7.07-0.04Athersys$146K0.00-$72.53M-$2.03N/A Which has more risk & volatility, OGEN or ATHX? Oragenics has a beta of 0.49, meaning that its stock price is 51% less volatile than the S&P 500. Comparatively, Athersys has a beta of -0.9, meaning that its stock price is 190% less volatile than the S&P 500. Does the media favor OGEN or ATHX? In the previous week, Athersys had 1 more articles in the media than Oragenics. MarketBeat recorded 1 mentions for Athersys and 0 mentions for Oragenics. Oragenics' average media sentiment score of 0.00 equaled Athersys'average media sentiment score. Company Overall Sentiment Oragenics Neutral Athersys Neutral Is OGEN or ATHX more profitable? Athersys' return on equity of 0.00% beat Oragenics' return on equity.Company Net Margins Return on Equity Return on Assets OragenicsN/A -2,087.95% -486.56% Athersys N/A N/A -223.03% Does the MarketBeat Community prefer OGEN or ATHX? Athersys received 365 more outperform votes than Oragenics when rated by MarketBeat users. Likewise, 58.21% of users gave Athersys an outperform vote while only 0.00% of users gave Oragenics an outperform vote. CompanyUnderperformOutperformOragenicsOutperform VotesNo VotesUnderperform Votes33100.00% AthersysOutperform Votes36558.21% Underperform Votes26241.79% Do institutionals & insiders believe in OGEN or ATHX? 18.7% of Oragenics shares are held by institutional investors. Comparatively, 19.4% of Athersys shares are held by institutional investors. 10.1% of Oragenics shares are held by insiders. Comparatively, 0.0% of Athersys shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryAthersys beats Oragenics on 9 of the 12 factors compared between the two stocks. Ad Colonial Metals“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! Get Athersys News Delivered to You Automatically Sign up to receive the latest news and ratings for ATHX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ATHX vs. The Competition Export to ExcelMetricAthersysPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$833,000.00$6.48B$5.07B$8.80BDividend YieldN/A8.11%4.99%4.07%P/E Ratio-0.014.9789.5613.60Price / SalesN/A371.451,224.8087.40Price / CashN/A52.5939.4536.27Price / BookN/A10.306.976.33Net Income-$72.53M$153.61M$119.04M$225.93M Athersys Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ATHXAthersysN/AN/AN/AN/A$833,000.00$146,000.00-0.0124OGENOragenicsN/A$0.27-6.2%N/AN/A$3.30M$40,000.000.005Analyst ForecastGap DownSHPHShuttle Pharmaceuticals0.5243 of 5 stars$0.90+0.2%N/AN/A$3.29MN/A0.005REVBRevelation Biosciences0.5809 of 5 stars$0.76flatN/A-96.1%$3.26MN/A0.0010Positive NewsGap UpDWTXDogwood TherapeuticsN/A$2.36-2.9%N/AN/A$3.14MN/A-0.374Negative NewsGap DownLIPOLipella Pharmaceuticals2.9825 of 5 stars$2.57+6.6%$16.00+522.6%-74.3%$3.11M$450,000.000.004News CoverageQNRXQuoin Pharmaceuticals2.2225 of 5 stars$0.61-2.3%$4.00+554.8%-84.9%$3.09MN/A0.004Negative NewsVRPXVirpax Pharmaceuticals2.8869 of 5 stars$0.63+2.1%$3.00+376.2%-90.7%$3.08MN/A0.007Gap UpENVBEnveric Biosciences2.461 of 5 stars$0.31-12.1%$10.00+3,149.9%-76.0%$3.06MN/A0.007Gap DownPBMPsyence BiomedicalN/A$0.05-4.0%N/AN/A$3.04MN/A0.00N/ANews CoverageGap DownINMInMed Pharmaceuticals0.2095 of 5 stars$4.11-2.8%N/A-47.8%$2.96M$4.60M0.0013 Related Companies and Tools Related Companies Oragenics Competitors Shuttle Pharmaceuticals Competitors Revelation Biosciences Competitors Dogwood Therapeutics Competitors Lipella Pharmaceuticals Competitors Quoin Pharmaceuticals Competitors Virpax Pharmaceuticals Competitors Enveric Biosciences Competitors Psyence Biomedical Competitors InMed Pharmaceuticals Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ATHX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Athersys, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Athersys With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATHX Stock Alerts